Answer ALL questions. For each question, there is ONE correct answer. Use the answer grid provided for ALL your answers.
|
|
- Ann Bridges
- 5 years ago
- Views:
Transcription
1 CLINICAL THERAPEUTICS 7: PSYCHIATRY PHA-MHBY Time allowed: 2 hours UNIVERSITY OF EAST ANGLIA School of Pharmacy Main Series UG Examination Part ONE Answer ALL questions. For each question, there is ONE correct answer. Use the answer grid provided for ALL your answers. Part TWO Answer TWO of the THREE questions. Use a SEPARATE answer book for EACH question in Part TWO. Each question has the same value. The marks distribution is shown as a percentage for each section of the question. Answer ALL parts of each of the individual questions you select. The mark allocation for the paper is: Part ONE carries 50% of the total mark. Part TWO carries 50% of the total mark. You are advised to spend approximately 1 hour on Part ONE and 1 hour on Part TWO. The paper consists of 11 pages in total. The following is provided: Multiple choice answer grid. Dictionaries are not permitted in this examination. Notes are not permitted in this examination. Do not turn over until you are told to do so by the Invigilator. Do not take this question paper out of the examinations room. (PHA-MHBY) Module Contact: Dr Chris Hamilton, PHA Copyright of the University of East Anglia Version 1
2 2 PART ONE SECTION A TYPE 1 MCQ Answer ALL questions. For each question, there is ONE correct answer. Use the answer grid provided for ALL your answers. 1. The suicide rate in bipolar disorder can be as high as 15-20%. Which ONE of the following has been shown to reduce the suicide rate? Carbamazepine Olanzapine Valproate Quetiapine Lithium 2. Which ONE of the following has been shown to be an effective treatment for acute bipolar depression? Fluoxetine Valproate Venlafaxine Quetiapine Lithium 3. For acute mania, which ONE of the following would NOT be a useful combination of therapy? Olanzapine plus lorazepam Risperidone plus carbamazepine Lithium plus lorazepam Olanzapine plus diazepam Quetiapine plus lorazepam 4. In the 2009 Cipriani meta-analysis published in the Lancet, which were the two antidepressants that came top of the efficacy and effectiveness table? Sertraline and escitalopram Venlafaxine and reboxetine Citalopram and agomelatine Mirtazapine and fluvoxamine Bupropion and mirtazapine
3 3 5. Stopping antidepressants abruptly can cause some discontinuation symptoms. One strategy with SSRIs can be to switch to another SSRI with a longer half-life. Which ONE of the following would be the best one to switch to? Paroxetine Fluoxetine Sertraline Venlafaxine Citalopram 6. When switching antidepressants, which ONE of the following is a major potential problem? Malignant hyperthermia Dry mouth and blurred vision Vivid dreams Raised LFTs Serotonin syndrome 7. Mrs. Fortywinks asks for your advice on her insomnia. In consultation you suggest some sleep hygiene approaches. Which ONE of the following would you NOT recommend? Day time sleeping Increase daily exercise (not in the evening) Reduce caffeine or alcohol intake, especially before bedtime Use anxiety management or relaxation techniques Develop a regular routine of rising and retiring at the same time each day, regardless of the amount of sleep taken 8. Which ONE of the following is CORRECT about the pharmacotherapy of Obsessive Compulsive Disorder (OCD)? Medicines with combined serotonin and noradrenaline reuptake inhibition are the most effective SSRIs need a high therapeutic dose for at least twelve weeks for full efficacy Mirtazapine is first-line treatment Most pharmacists have OCD Cognitive Behavioural Therapies have little or no role in augmenting medicines TURN OVER
4 4 9. Which ONE of the following is NOT a common symptom or consequence of ADHD in adults? Insomnia Depression Substance misuse Road accidents Self harming 10. Which ONE of the following statements about the anti-psychotic drug haloperidol and its analogues is FALSE? Conversion into the decanoate ester leads to a form that can be injected every 4 to 6 weeks It is a butyrophenone derivative For an active analogue, substituents are usually 1,3- to the nitrogen in the saturated piperidine ring For an active analogue, the aromatic ring is usually substituted with fluorine but may also carry a methoxy group The starting point in the development of haloperidol was the analgesic pethidine 11. Which of the following statements regarding clozapine is CORRECT? Clozapine is effective to control the positive and negative symptoms of schizophrenia by blocking dopamine receptors Clozapine has been associated with a low risk of tardive dyskinesia Clozapine should only be initiated when a relapse is expected, or when symptoms are particularly troublesome Clozapine may be metabolised more slowly in smokers The aim of carefully titrating clozapine dosage at the beginning is to avoid agranulocytosis 12. Which one of the following is CORRECT regarding extrapyramidal movement disorders? They are irreversible on stopping antipsychotics They are more likely to occur in patients taking second-generation antipsychotics than first-generation antipsychotics Dystonic reactions more commonly affect muscles of the back and arms Parkinsonian symptoms have been associated with a gradual onset (months to years) Akathisia is dose dependent
5 5 13. A 34 year old man has been taking sertraline for generalized anxiety. He has been on a dose of 100 mg per day for 12 weeks and feels that he is still not well. Which ONE of the following should be the next step? Continue to take 100 mg of sertraline as it should take another 12 weeks for optimal effect Increase the dose of sertraline up to the maximum of 200 mg per day Switch over to a Noradrenaline Reuptake Inhibitor (NARI) Add in a regular benzodiazepine Change sertraline to venlafaxine as it is the recommended first line treatment for generalised anxiety 14. For the treatment of Obsessive Compulsive Disorder (OCD) which ONE of the following is CORRECT? Imipramine is the second line treatment SSRI treatment should be started at higher dose Effective treatment should be continued for 1-2 years before considering withdrawal When discontinuing treatment, it should be done rapidly over a couple of weeks. Benzodiazepines are useful for short term treatment 15. A patient has been taking lorazepam 2 mg daily for several years. Which ONE of the following is the recommended advice for withdrawing a benzodiazepine? Convert to the equivalent dose of diazepam and reduce dose by one half every 2 weeks Convert to the equivalent dose of diazepam and reduce dose by one eighth every 4 weeks Convert to the equivalent dose of diazepam and reduce dose by one half every 4 weeks Convert to the equivalent dose of diazepam and reduce dose by one eighth every 2 weeks Convert to the equivalent dose of diazepam and reduce dose by one quarter dose every 2 weeks 16. Which ONE of the following is NOT a complication of alcohol misuse? Wernicke-Korsakoff syndrome Cardiomyopathy Depression Mallory-Weiss syndrome Neuroleptic malignant syndrome TURN OVER
6 6 17. Which ONE of the following statements about methadone is FALSE? Methadone is a natural opiate agonist Methadone does not cause congenital abnormalities in the newborn Methadone has a half-life of hours Methadone is available in various forms Methadone has good cross tolerance with other opiates 18. Benzodiazepines are recognised as the treatment of choice for alcohol withdrawal. They are cross tolerant with alcohol and have anticonvulsant properties. Which one of the following statements is FALSE? Chlordiazepoxide is the benzodiazepine of choice in uncomplicated withdrawal A longer acting benzodiazepine should be used in patients with alcoholic liver disease A typical regimen for moderate alcohol dependence might be chlordiazepoxide 10 mg-20 mg four times each day Mild alcohol dependence requires small doses of chlordiazepoxide or may be managed without medication Benzodiazepines are typically given for 7-10 days in alcohol withdrawal 19. Which ONE of the following symptoms of Behavioural and Psychological Symptoms of Dementia (BPSD) is unlikely to respond to antipsychotic drug treatment? Aggression Agitation Apathy Anxiety Wandering 20. Following analysis of unpublished & published data in 2004, initial warnings were issued in the UK & USA regarding increased mortality in patients with dementia taking certain medication. Which ONE of the following did these warnings apply to? Antidepressants Benzodiazepines Anticholinesterases Antipsychotics Mood stabilisers
7 7 21. Which ONE of the following CNS neurotransmitters is NOT an excitatory or inhibitory amino acid? Cholecystokinin L-Glutamate Aspartate GABA Glycine 22. Which ONE of the following describes the GABAA receptor in the CNS? It is an ionotropic receptor that selectively conducts Cl - through its pore It is an ionotropic receptor that selectively conducts K + through its pore It is an ionotropic receptor that selectively conducts Na + through its pore It is a metabotropic receptor It is an ionotropic receptor that selectively conducts Mg + through its pore 23. In which ONE of these regions of the brain do higher order activities and conscious thought originate? Spinal cord Cerebellum Hypothalamus Cortex Medulla 24. Unless a large scale clinical trial is carried out, the safest antidepressant in epilepsy will remain unknown. During a ward round, Dr. Jolly asks you which antidepressant would be a suitable choice for a patient who is well controlled with her epilepsy. Given the lack of data which ONE do you suggest avoiding? Sertraline Citalopram Bupropion Venlafaxine Dosulepin TURN OVER
8 8 SECTION B TYPE 2 MCQ Answer ALL questions. For each question there is ONE correct answer. Use the answer grid provided for ALL your answers. Decide which of the responses to the following questions is/are correct, then choose: If (i), (ii) and (iii) are correct If (i) and (ii) only are correct If (ii) and (iii) only are correct If (i) only is correct If (iii) only is correct 25. Buprenorphine has shown to possess several advantages over methadone including: (i) (ii) (iii) Buprenorphine has a better safety profile in overdose Buprenorphine has been shown to produce milder opioid withdrawal symptoms (OWS) Buprenorphine can be crushed and injected 26. Mr Weed would like to transfer from 8 mg buprenorphine to naltrexone. His keyworker asks you how he could safely do this and you advise to: (i) (ii) (iii) Stop buprenorphine and start with a 50 mg naltrexone tablet the following day and monitor for withdrawals Carry out a naloxone challenge before commencing naltrexone Reduce buprenorphine to 0.4 mg per day and wait 3-4 days before starting naltrexone 27. When Mrs Ginny Tonique collects her prescription she asks you if she can drink alcohol with the medication. During the consultation with Ginny you perform the AUDIT C questionnaire screening tool. (i) (ii) (iii) The screening tool asks 3 questions The tool cannot determine dependency on alcohol The tool indicates what intervention is needed 28. Some of the guidance on prescribing hypnotics would include: (i) (ii) (iii) Prescribe the lowest effective dose Use intermittent dosing (alternate nights or less) where possible Prescribing for the short term (up to four weeks) is not effective END OF TYPE 2 MCQs
9 9 SECTION C TYPE 3 MCQ Answer ALL questions. For each question there is ONE correct answer. Use the answer grid provided for ALL your answers. The questions consist of a statement in the left-hand column followed by a second statement in the right-hand column. Decide whether the first statement is TRUE or FALSE. Decide whether the second statement is TRUE or FALSE. Then choose: A B C D E If both statements are TRUE and the second statement is a correct explanation of the first statement. If both statements are TRUE but the second statement is NOT a correct explanation of the first statement. If the first statement is TRUE but the second statement is FALSE. If the first statement is FALSE but the second statement is TRUE. If both statements are FALSE. Directions Summarised A B C D E First Statement False False Second Statement False False 2 nd statement is a correct explanation of the first 2 nd statement is NOT a correct explanation of the first 29. FIRST STATEMENT SECOND STATEMENT GABA is the major inhibitory transmitter in the brain. Glutamate opposes GABA at the same receptor site. 30. FIRST STATEMENT Stimulating dopamine receptors in the tuberinfundibular system can cause raised prolactin. SECOND STATEMENT Raised prolactin can cause milk production. END OF PART ONE TURN OVER
10 10 PART TWO Answer TWO of the THREE questions in this section. Use a SEPARATE answer book for EACH question. 31. Answer ALL parts (a) to (c). A recent newspaper headline stated that a paranoid schizophrenic was a Mad axeman killer when referring to a death that he had caused. This can create a prejudice against such people. (a) What is schizophrenia, what are the main drug treatments and the relative adverse effect profile of these treatments? [70%] (b) How can adverse effects be managed and what are the pharmaceutical care issues around drug treatments for schizophrenia? [20%] (c) Should the public be scared of people with schizophrenia? Briefly explain your answer. Why might people with schizophrenia pose a threat to themselves and others? [10%] 32. Answer BOTH parts. Miss Teek, a shy young colleague at work, has been diagnosed as suffering from social anxiety. She has been prescribed a benzodiazepine and asks you about it. (a) What are the signs and symptoms of social anxiety and social phobia? [20%] (b) Discuss the use of benzodiazepines. Are they effective and are they addictive? [80%]
11 Answer ALL parts (a) to (c). Between 1985 and 1999 the suicide rate in the USA fell by 13.5% and over that time the use of antidepressants rose 400%. A similar trend has been seen in Japan. (a) What are the main symptoms of depression? [20%] (b) Discuss the role of neurotransmitters in depression [20%] (c) Discuss which class of antidepressant should be considered first line in the treatment of depression and why. What are their main side effects and drug interactions? What advice or counselling should you give a person when first prescribed these drugs? [60%] END OF PAPER
Part ONE Answer ALL questions. Write the correct answer CLEARLY in the answer grid provided.
UNIVERSITY OF EAST ANGLIA School of Pharmacy Main Series UG Examination 2012-2013 CLINICAL THERAPEUTICS 7: PSYCHIATRY PHA-MHBY Time allowed: 2 hours Part ONE Answer ALL questions. Write the correct answer
More informationIntroduction to Drug Treatment
Introduction to Drug Treatment LPT Gondar Mental Health Group www.le.ac.uk Introduction to Psychiatric Drugs Drugs and Neurotransmitters 5 Classes of Psychotropic medications Mechanism of action Clinical
More informationPregnancy. General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition)
Pregnancy General Principles of Prescribing in Pregnancy (The Maudsley, 12 th Edition) In all women of child bearing potential Always discuss the possibility of pregnancy; half of all pregnancies are unplanned
More informationTreatment Options for Bipolar Disorder Contents
Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8
More informationMental illness A Broad Overview. Dr H Pathmanandam March 2017
Mental illness A Broad Overview Dr H Pathmanandam March 2017 Introduction Mental disorders are common in primary and secondary care Many are not recognised and not treated Some receive unnecessary or inappropriate
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX
A Adderall Counterfeit, 31 addiction, internet CBT, 55 ADHD Adjunctive Guanfacine, 11 Counterfeit Adderall, 31 Developmental Trajectory and Risk Factors, 5 Dopamine Transporter Alterations, 14 Extended-Release
More informationPRESCRIBING GUIDELINES
The Maudsley The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust PRESCRIBING GUIDELINES 10th Edition David Taylor Carol Paton Shitij Kapur informa healthcare Contents Authors
More informationVolume 4; Number 5 May 2010
Volume 4; Number 5 May 2010 CLINICAL GUIDELINES FOR ANTIDEPRESSANT USE IN PRIMARY AND SECONDARY CARE Lincolnshire Partnership Foundation Trust in conjunction with Lincolnshire PACEF have recently updated
More informationThis initial discovery led to the creation of two classes of first generation antidepressants:
Antidepressants - TCAs, MAOIs, SSRIs & SNRIs First generation antidepressants TCAs and MAOIs The discovery of antidepressants could be described as a lucky accident. During the 1950s, while carrying out
More informationManual of Clinical Psychopharmacology
Manual of Clinical Psychopharmacology Fourth Edition Alan F. Schatzberg, M.D. Kenneth T. Norris, Jr., Professor and Chairman, Department of Psychiatry and Behavioral Sciences, Stanford University School
More informationA guide to reducing or stopping mental health medication. Notes for prescribers
A guide to reducing or stopping mental health medication Notes for prescribers 1 Prescribers notes for reducing or stopping mental health medication These notes are written to augment the information for
More informationMedication management of anxiety & depression. Dr Katie Simpson GP Mental health lead East Berks CCG
Medication management of anxiety & depression Dr Katie impson GP Mental health lead East Berks CCG NICE guidelines for Anxiety tepped Care RIs and NRIs in Anxiety disorders RI ertraline Citalopram Fluoxetine
More informationThings You Might Not Know About Psychotropic Medications But Wish You Did
Things You Might Not Know About Psychotropic Medications But Wish You Did John E. Dunne, MD December 3, 2016 PAL Conference Conflicts of Interest None to report I am employed by Seattle Children s and
More informationPsychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI
Regional Affective Disorders Service Psychopharmacology Northumberland, Tyne and Wear NHS Trust Hamish McAllister-Williams Reader in Clinical Psychopharmacology Department of Psychiatry, RVI Intro NOT
More informationStudy Guide Unit 3 Psych 2022, Fall 2003
Psychological Disorders: General Study Guide Unit 3 Psych 2022, Fall 2003 1. What are psychological disorders? 2. What was the main treatment for some psychological disorders prior to the 1950 s? 3. What
More informationIndex. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers
Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) a-adrenergic blockers for PTSD, 798 b-adrenergic blockers for PTSD, 798 Adrenergic
More informationNSFT Formulary. Double Red Not recommended for routine use/not commissioned. These drugs have not been recommended for routine use at present.
Traffic Light Status NSFT Formulary Not recommended for routine use/not commissioned. These drugs have not been recommended for routine use at present. Hospital/Specialist only Drugs for which the Trust
More informationAppendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over)
Appendix 4B - Guidance for the use of Pharmacological Agents for the Treatment of Depression in Adults (18 years and over) Introduction / Background Treatment comes after diagnosis Diagnosis is based on
More informationMedications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation
Medications for Anxiety & Behavior in Williams Syndrome Christopher J. McDougle, M.D. Director, Lurie Center for Autism Professor of Psychiatry and Pediatrics Massachusetts General Hospital and MassGeneral
More informationThe Maudsley Prescribing Guidelines in
The Maudsley Prescribing Guidelines in 11th Edition David Taylor Director of Pharmacy and Pathology South London and Maudsley NHS Foundation Trust; Professor King's College London, London, UK Paton Chief
More informationPROCEDURE REF NO SABP/EXECUTIVE BOARD/0017
PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017 NAME OF GUIDELINE REASON FOR GUIDELINE WHAT THE GUIDELINE WILL ACHIEVE? WHO NEEDS TO KNOW ABOUT IT? Medicines Guideline: Hypnotic Medication Compliance with NICE
More informationMEDICATION ALGORITHM FOR ANXIETY DISORDERS
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences MEDICATION ALGORITHM FOR ANXIETY DISORDERS RYAN KIMMEL, MD MEDICAL DIRECTOR HOSPITAL PSYCHIATRY UNIVERSITY OF WASHINGTON
More informationPediatric Psychopharmacology
Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders
More informationMedication for Anxiety and Depression. PJ Cowen Department of Psychiatry, University of Oxford
Medication for Anxiety and Depression PJ Cowen Department of Psychiatry, University of Oxford Topics Medication for anxiety disorders Medication for first line depression treatment Medication for resistant
More informationPsychobiology Handout
Nsg 85A / Psychiatric Page 1 of 7 Psychobiology Handout STRUCTURE AND FUNCTION OF THE BRAIN Psychiatric illness and the treatment of psychiatric illness alter brain functioning. Some examples of this are
More informationReducing the Anxiety of Pediatric Anxiety Part 2: Treatment
Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment Lisa Lloyd Giles, MD Medical Director, Behavioral Consultation, Crisis, and Community Services Primary Children s Hospital Associate Professor,
More informationSmoking Cessation Pharmacotherapy Guidelines
Smoking Cessation Pharmacotherapy Guidelines INTRODUCTION This guideline is based on public health guidance 10 Smoking Cessation Services issued by the National Institute for Health and Clinical Excellence
More informationGuidance on the use of Antidepressants for the Treatment of Unipolar Depression and Anxiety Spectrum Disorders in adults (Version 3 October 2014)
Guidance on the use of Antidepressants for the Treatment of Unipolar Depression and Anxiety Spectrum Disorders in adults (Version 3 October 2014) Date of Preparation: September 2014 Date for next full
More informationPerinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs
Perinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs (Version 3 January 2015) Principal Author: Dr Jenny Cooke Consultant Psychiatrist, Brighton & Hove Perinatal Mental Health Service
More informationThe treatment of bipolar disorder in adults, children and adolescents
DRAFT FOR CONSULTATION The treatment of bipolar disorder in adults, children and adolescents The paragraphs in the draft are numbered for the purposes of consultation. The final version will not contain
More informationSwitching antipsychotics: Basing practice on pharmacology & pharmacokinetics
Switching antipsychotics: Basing practice on pharmacology & pharmacokinetics John Donoghue Liverpool L imagination est plus important que le savoir Albert Einstein Switching Antipsychotics: Objectives
More informationIntroduction to psychotropic medications JAYNE CAMPBELL
Introduction to psychotropic medications JAYNE CAMPBELL Introduction Psychotropic medications are prescription drugs that are commonly used to control some symptoms associated with many different types
More informationAdverse events of common psychiatric medications: an umbrella review
Adverse events of common psychiatric medications: an umbrella review Katrina Bartellas, 1 Thomas Bajorek 1 Sarah Stockton, 1 Stefan Leucht, 2 Andrea Cipriani, 1 Seena Fazel 1 1 Department of Psychiatry,
More informationPsychotropic Medication Use in Dementia
Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician,
More informationReview of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)
Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder
More informationTreat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused
Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines
More informationCHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XV, 2013 INDEX
A acceptance and commitment therapy Posttraumatic Stress, 69 ADHD Adjunctive Fatty Acids, 5 Adjunctive Guanfacine Pharmacokinetics, 27 Amantadine, 21 Atomoxetine, 23 Cancer Risk, 31 CBT for Comorbid Anxiety,
More informationPsychiatric Medication Guide
Psychiatric Medication Guide F O R : N E O N P R I M A R Y H E A L T H C A R E P R O V I D E R S B Y : M I C H E L L E R O M E R O, D O M A Y, 2 0 1 3 Anti-depressants TCA s & MAOI s (Tricyclic Antidepressants
More informationThe Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability
The Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability Danielle Adams Principal Clinical Pharmacist Pharmacy and Medicines Optimisation Team HPFT July 2017 1
More informationPSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer
PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally
More informationAntidepressants. Dr Malek Zihlif
Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction and the deferential diagnosis of psychiatric
More informationMood Disorders.
Mood Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner
More informationAnxiety Disorders.
Anxiety Disorders Shamim Nejad, MD Medical Director, Psycho-Oncology Services Swedish Cancer Institute Swedish Medical Center Seattle, Washington Shamim.Nejad@swedish.org Disclosures Neither I nor my spouse/partner
More informationGUIDELINES FOR THE USE OF PSYCHOACTIVE MEDICATIONS IN INDIVIDUALS WITH CO-OCCURRING SUBSTANCE USE DISORDERS
City and County of San Francisco Mayor Gavin Newsom Department of Public Health Community Behavioral Health Services 1380 Howard Street 5 th Floor San Francisco, CA 94103 GUIDELINES FOR THE USE OF PSYCHOACTIVE
More informationPSYCHIATRY DRUG ALERTS, VOLUME XXVIII, 2014 INDEX
A acamprosate ADHD Generic Methylphenidate Equivalence, 84 Methylphenidate in Pregnancy, 9 Stimulants in Pregnancy, 50 adverse effects Antidepressant-Induced Jitteriness, 94 Antidepressants and Sexual
More informationDEMENTIA AND MEDICATION
DEMENTIA AND MEDICATION Dr. Siobhan Ni Bhriain, MRCP, MRCPsych. Clinical Director, Tallaght and SJH MHS, Consultant Old Age Psychiatrist, Chair, DSIDC Steering Committee. SUMMARY OF TODAY S TALK Dementia-definition,
More informationBenzodiazepines: risks, benefits or dependence
Benzodiazepines: risks, benefits or dependence A re-evaluation Council Report CR 59 January 1997 Royal College of Psychiatrists, London Due for review: January 2002 1 Contents A College Statement 3 Benefits
More informationPsychopharmacology: A Comprehensive Review
Psychopharmacology: A Comprehensive Review 1) The association between a chemical compound and its biological activity, pioneered by Bovet and colleagues in the 1930s is known as a) Symbiosis b) Structure-activity
More informationMental Illness. Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling
Mental Illness Doreen L. Rasp, APN, FNP, PMHNP Advanced Behavioral Counseling Moodiness Changing Bodies Narcissism Self-Esteem Ignorant Naïve Insecure Self-Centered Independent Adolescence Disorders Affecting
More informationSafe transfer of prescribing guidance
Safe transfer of prescribing guidance TEWV Prescriber Summary Application required before prescribing Products requiring an application, before prescribing, using the single application form Unlicensed
More informationBest Practices in Prescribing Benzodiazepines. Michael Carlisle, DO Medical Director University Hospitals Geauga Medical Center
Best Practices in Prescribing Benzodiazepines Michael Carlisle, DO Medical Director University Hospitals Geauga Medical Center Objectives To review current practice guidelines in benzodiazepine prescribing
More informationGuidance on the use of Antidepressants for the Treatment of Unipolar Depression and Anxiety Spectrum Disorders in adults (Version 4.
Guidance on the use of Antidepressants for the Treatment of Unipolar Depression and Anxiety Spectrum Disorders in adults (Version 4.1 December 2018) Date of Preparation: January 2018 (with addition of
More informationAntidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych
Antidepressants: Prof. Riyadh Al_Azzawi F.R.C.Psych A. Heterocyclic antidepressants: (tricyclic and tetracyclic ), e.g.amitryptaline,imipramine. B. Monoamine oxidase inhibitors(m.a.o.i), e.g.phenelzine.
More informationDementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist
Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist Medication Dosage Indication for Use Aricept (donepezil) Exelon (rivastigmine) 5mg 23mg* ODT 5mg Solution
More informationTHIOTHIXENE. THERAPEUTICS Brands Navane see index for additional brand names. Generic? Yes
THIOTHIXENE THERAPEUTICS Brands Navane see index for additional brand names Generic? Yes Class Conventional antipsychotic (neuroleptic, thioxanthene, dopamine 2 antagonist) Commonly Prescribed for (bold
More informationDISEASES AND DISORDERS
DISEASES AND DISORDERS 13. The mood (affective) disorders 99 14. The psychotic disorders: schizophrenia 105 15. The anxiety and somatoform disorders 111 16. Dementia and delirium 117 17. Alcohol and substance-related
More informationPSYCHIATRIC MANAGEMENT IN PRIMARY CARE. Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust
PSYCHIATRIC MANAGEMENT IN PRIMARY CARE Dr Fayyaz Khan MBBS, MRCPsych, MSc Consultant Psychiatrist (Locum) Mersey Care NHS Trust Areas to cover Mood Disorders Anxiety Disorders Miscellaneous Conditions
More informationUse of Psychotropic Medications in Older Adults with Dementia!
Use of Psychotropic Medications in Older Adults with Dementia! Deepa Pattani, PharmD, RPh Owner: PrevInteract Health Deepa.Pattani@PrevInteract.com 972-372-9775 About Me Deepa Pattani, PharmD, RPh with
More informationAntidepressant Treatment of Depression
Antidepressant Treatment of Depression PLEASE REFER TO INTEGRATED CARE PATHWAY FOR INFORMATION RELATING TO THE OVERALL MANAGEMENT OF DEPRESSION SSRI s are first choice agents because they are as effective
More informationKEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.
KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised
More informationPsychiatry in Primary Care: What is the Role of Pharmacist?
Psychiatry in Primary Care: What is the Role of Pharmacist? Benjamin Chavez, PharmD, BCPP, BCACP Clinical Associate Professor Director of Behavioral Health Pharmacy Services January 12, 2019 Disclosure
More informationPsychotropic Strategies Handout Package
Psychotropic Strategies Handout Package Psychotropic Strategies Learning Objectives Utilize all clinical information available Assess the patient s overall condition this is essential Basic Principles
More informationClinical Guideline / Formulary Document Pharmacy Department Medicines Management Services
Clinical Guideline / Formulary Document Pharmacy Department Medicines Management Services DEPRESSION Pharmacological Treatment of Depression NICE guidelines suggest the following stepped care model also
More informationProfessor Tony Holland, Department of Psychiatry, University of Cambridge
INFORMATION SHEET The Use of Medication for Challenging Behaviour Professor Tony Holland, Department of Psychiatry, University of Cambridge Introduction Challenging behaviours displayed by people with
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationDepression: selective serotonin reuptake inhibitors
Depression: selective serotonin reuptake inhibitors Selective serotonin reuptake inhibitors (SSRIs) are considered first-line treatment for the majority of patients with depression. citalopram and fluoxetine
More informationDepression in adults: treatment and management
1 2 3 4 Depression in adults: treatment and management 5 6 7 8 Appendix V3: recommendations that have been deleted of changed from 2009 guideline Depression in adults: Appendix V3 1 of 22 1 Recommendations
More informationPharmacological Treatment of Anxiety & Depressive Disorders
Pharmacological Treatment of Anxiety & Depressive Disorders Dr Gary Jackson (MB BCh FRCPsych) Consultant Psychiatrist The Priory Hospital Chelmsford Wellesley Hospital Southend-on-Sea Medical Secretary:
More informationPsychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis
Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious
More informationKey concepts in psychopharmacology
Key concepts in psychopharmacology David Nutt Anne Lingford-Hughes Agonists, antagonists and partial agonists and antagonists at dopamine D 2 receptors Full agonist: dopamine, apomorphine Abstract Drugs
More informationMental Health Medicines Management Pilot. Community Pharmacy. High Dose Antipsychotic Screening, Education & Advice Service
Mental Health Medicines Management Pilot Community Pharmacy High Dose Antipsychotic Screening, Education & Advice Service Approved Version 1 Date of First Issue Review Date Date of Issue Author / Contact
More information4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies
Child & Adolescent Behavioral Medicine & Medication Therapies Brian J Cowles, PharmD Associate Professor of Pharmacy Practice Albany College of Pharmacy & Health Sciences; Vermont Campus Behavioral Medicine
More informationAntipsychotics. Something Old, Something New, Something Used to Treat the Blues
Antipsychotics Something Old, Something New, Something Used to Treat the Blues Objectives To provide an overview of the key differences between first and second generation agents To an overview the newer
More informationStop smoking products guidance
Stop smoking products guidance Ref: Status: Approved Stop smoking products guidance Page 1 of 15 Approval date: 22 November 2018 Contents 1. Purpose... 3 2. Related documents... 3 3. Guidance... 3 3.1
More informationDrugs used to relieve behavioural and psychological symptoms in dementia
alzheimers.org.uk Drugs used to relieve behavioural and psychological symptoms in dementia People with dementia may develop behavioural and psychological symptoms including restlessness, aggression, delusions,
More informationDrugs used for the treatment of depression Selective Serotonin Reuptake Inhibitors Tricyclic and related antidepressants Others antidepressants
Central Nervous System Drugs used for the treatment of depression Anxiolytics and hypnotics Drugs used in psychosis and related disorders Drugs used in substance dependence for patients with established
More informationPain CONCERN. Medicines for long-term pain. Antidepressants
Pain CONCERN Medicines for long-term pain Antidepressants Many people living with long-term pain (also known as chronic or persistent pain) are worried about using medicines like antidepressants. They
More informationPsycholeptics, anti-depressants, antiepileptic, anti-ra and anti-spastic medications available at Zithulele hospital
Psycholeptics, anti-depressants, antiepileptic, anti-ra and anti-spastic medications available at Zithulele hospital Note that with the exception of NSAIDs, none of the following medications are available
More informationInformation leaflet for primary care: Agomelatine
Information leaflet for primary care: Agomelatine Background information Agomelatine is an antidepressant indicated for the treatment of major depressive episodes in adults. Agomelatine is a melatonin
More informationSouth London and the Maudsley NHS Foundation Trust Medicines Formulary
South London and the Maudsley NHS Foundation Trust Medicines Formulary Medicine Formulations Restrictions Additional Information / Related NICE Technology Appraisal 4.1 Hypnotics and anxiolytics 4.1.1
More informationJoint Formulary for Psychotropic Medication.
Joint for Psychotropic Medication. This document has been produced in collaboration with the Lancashire Commissioning Support Unit Page 1 Table of Contents Section Page Number Page 2 Definition of categories
More informationNew Medications in Early Psychosis
New Medications in Early Psychosis Jean Starling Department of Psychological Medicine, the Children s Hospital at Westmead Department of Psychological Medicine and Department of Paediatrics and Child Health,
More informationDocument Title Pharmacological Management of Generalised Anxiety Disorder
Document Title Pharmacological Management of Generalised Anxiety Disorder Document Description Document Type Policy Service Application Trust Wide Version 1.1 Policy Reference no. POL 201 Lead Author(s)
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
Step 3: GAD with marked functional impairment or that has not improved after step 2 interventionsentions bring together everything NICE says on a topic in an interactive flowchart. are interactive and
More informationGuidelines on Choice and Selection of Antidepressants for the Management of Depression
Guidelines on Choice and Selection of Antidepressants for the Management of Depression 1. Introduction This guidance should be considered as part of a stepped care approach in the management of depressive
More informationSeroquel XR. quetiapine fumarate APPROVED PRODUCT INFORMATION
Seroquel XR quetiapine fumarate APPROVED PRODUCT INFORMATION NAME OF THE MEDICINE Quetiapine fumarate Chemical Name: Bis[2-(2-[4-(dibenzo[b,f][1,4]-thiazepin-11-yl)piperazin-1-yl] ethoxy) ethanol] fumarate.
More informationQUEPINE XR PRODUCT INFORMATION. Name of the medicine. Description. Pharmacology
QUEPINE XR PRODUCT INFORMATION Name of the medicine Quetiapine fumarate. The chemical name is Bis[2-(2-[4-(dibenzo[b,f][1,4]-thiazepin-11-yl)piperazin- 1-yl] ethoxy) ethanol] fumarate. Its structural formula
More informationProfessor Tony Holland, Department of Psychiatry, University of Cambridge
INFORMATION SHEET The Use of Medication in the Treatment of Challenging Behaviour Professor Tony Holland, Department of Psychiatry, University of Cambridge Introduction The use of medication is but one
More informationBIOLOGICAL TREATMENT IN PSYCHIATRY. PTE ÁOK Dept.of Psychiatry Pécs
BIOLOGICAL TREATMENT IN PSYCHIATRY PTE ÁOK Dept.of Psychiatry Pécs 1 SGA effects pharmacokinetic effect chemical strucrure Receptor block D2 5-HT2 α1 H-1 M Selectíve DA (D2D3) antagonists Benzamids Amisulpiride
More informationPsychotropic Medication. Including Role of Gradual Dose Reductions
Psychotropic Medication Including Role of Gradual Dose Reductions What are they? The phrase psychotropic drugs is a technical term for psychiatric medicines that alter chemical levels in the brain which
More informationGREATER MANCHESTER INTERFACE PRESCRIBING GROUP
GREATER MANCHESTER INTERFACE PRESCRIBING GROUP On behalf of the GREATER MANCHESTER MEDICINES MANAGEMENT GROUP SHARED CARE GUIDELINE FOR THE PRESCRIBING OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIs)
More information4.3 Antidepressants (ADDs) BNF Section 4.3
4.3 Antidepressants (ADDs) BNF Section 4.3 The aim of this guidance is to provide prescribing guidance and highlight good practice. It is not intended to be a comprehensive practice treatment guideline.
More informationClinical Guideline for the Management of Bipolar Disorder in Adults
Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:
More informationDepression: management of depression in primary and secondary care
Issue date: December 2004, with amendments April 2007 Quick reference guide (amended) Depression: management of depression in primary and secondary care Amendment of recommendations concerning venlafaxine:
More informationThis document has been produced in collaboration with the Lancashire Commissioning Support Unit
Joint for Psychotropic Medication. This document has been produced in collaboration with the Lancashire Commissioning Support Unit Date: December 2014. Reviewed August 2016. Next review Date April 2019
More informationFinal Exam PSYC2022. Fall (1 point) True or False. The DSM-IV describes the symptoms of acute intoxication with cannabis.
Final Exam PSYC2022 Fall 1998 (2 points) Give 2 reasons why it is important for psychological disorders to be accurately diagnosed. (1 point) True or False. The DSM-IV describes the symptoms of acute intoxication
More informationFor: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013
For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013 This power point is only a guideline for recommendations in the treatment of psychiatric disorders. This is not comprehensive. Please
More informationPRODUCT INFORMATION TEVATIAPINE XR (quetiapine fumarate)
PRODUCT INFORMATION TEVATIAPINE XR (quetiapine fumarate) NAME OF THE MEDICINE Active ingredient: Quetiapine fumarate Chemical Name: Bis[2-(2-[4-(dibenzo[b,f][1,4]-thiazepin-11-yl)piperazin-1-yl] ethoxy)
More informationPRESCRIBING PRACTICE IN DELIRIUM. John Warburton Critical Care Pharmacist
PRESCRIBING PRACTICE IN DELIRIUM John Warburton Critical Care Pharmacist Learning outcomes Modifiable medication risk factors for delirium An appreciation of contributing factors modifiable with medicines
More information